Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05885646
Other study ID # 49RC23_0073
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 18, 2023
Est. completion date September 2024

Study information

Verified date January 2024
Source University Hospital, Angers
Contact Patrick Van Bogaert, Professor
Phone 02.41.35.48.46
Email Patrick.VanBogaert@chu-angers.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The effect of sulthiame on EEG has been studied in epilepsy syndromes of childhood with sleep activation by comparing sleep EEG obtained at baseline and after 4 weeks of treatment. The aim of the study is to know if an effect is still identifiable after 2 weeks of treatment by performing sleep EEG recordings after 2 and 4 weeks of treatment, respectively.


Recruitment information / eligibility

Status Recruiting
Enrollment 15
Est. completion date September 2024
Est. primary completion date July 2024
Accepts healthy volunteers
Gender All
Age group 6 Years to 15 Years
Eligibility Inclusion Criteria: - Diagnosis of epilepsy syndromes of childhood with sleep activation - Failure of at least two anti-epileptic drugs (AED) - Sleep EEG performed in the last 7 days before inclusion and showing interictal epileptiform discharges (baseline EEG) Exclusion Criteria: - Previous trial with sulthiame - More than 2 AED at inclusion - Use of corticosteroids at inclusion - Change in the anti-epileptic treatment in the 7 days before baseline EEG

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Sulthiame
Sulthiame add-on according to good clinical practice in these childhood epilepsy syndromes

Locations

Country Name City State
France Angers University Hospital, Pediatric department Angers
France Strasbourg University Hospital, Pediatric department Strasbourg
France Toulouse University Hospital, Pediatric Neurology Department Toulouse

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Angers

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of patients showing improved sleep EEG at day 14 compared to baseline EEG 14 days
See also
  Status Clinical Trial Phase
Recruiting NCT06202976 - Mapping Epileptic Networks Using Multimodal Imaging
Recruiting NCT04770337 - Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy N/A
Completed NCT04545346 - The Potential of a Low Glutamate Diet as a Treatment for Pediatric Epilepsy N/A
Completed NCT06400966 - The Effect of Jigsaw Technique on Childhood Epileptic Seizure Management Knowledge and Attitudes of Nursing Students N/A
Not yet recruiting NCT06388577 - The Effect of the Training Programme Based on the Health Promotion Model Given to Parents N/A
Not yet recruiting NCT06402526 - Evaluating the Efficacy of a Mobile Epilepsy Education Application N/A
Terminated NCT04639310 - XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy Phase 3
Withdrawn NCT04308252 - Comparison of Microbiome Composition and Biomarkers in Pharmaco Resistant and Pharmaco-Sensitive Epilepsy
Recruiting NCT06300814 - The Effect of Exercise and Music on Sleep, Quality of Life and Emotional State in Children With Epilepsy N/A
Active, not recruiting NCT03916848 - Novel Network Analysis of Intracranial Stereoelectroencephalography N/A
Recruiting NCT05439876 - Getting SMART for Pediatric Epilepsy Phase 2/Phase 3
Recruiting NCT05323682 - Physical Excercise Program in Children With Drug-resistant Epilepsy N/A
Recruiting NCT04584385 - Advanced EEG Technology in Childhood Epilepsy
Not yet recruiting NCT04219930 - Nucleotide Protein -3 in Epileptic Children
Completed NCT04020484 - Making Mindfulness Matter© in Children With Epilepsy N/A
Recruiting NCT06093490 - Detecting Absence Seizures Using Hyperventilation and Eye Movement Recordings
Completed NCT05675254 - The Prevalence and Risk Factors of Coagulopathy in Pediatric Epilepsy Surgery Patients
Recruiting NCT05740423 - Standardization of Anti-Seizure Medications Withdrawals After Seizure Remission in Young Patients With Epilepsy
Terminated NCT04912856 - An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE Phase 3
Recruiting NCT06310954 - Ketogenic Diet in Pediatric Intractable Epilepsy N/A